March 31, 2025 - 17:39
The company, which uses artificial intelligence to develop new treatments, has successfully secured funding from the venture capital firm Thrive Capital. This investment marks a significant milestone for Isomorphic Labs, as it continues to leverage cutting-edge technology to revolutionize the pharmaceutical industry.
With the integration of AI into drug discovery and development, Isomorphic Labs aims to enhance the efficiency and effectiveness of creating new therapies. The backing from Thrive Capital not only provides financial support but also validates the company’s innovative approach to tackling complex medical challenges.
As the demand for faster and more effective drug development grows, Isomorphic Labs is positioned to play a pivotal role in shaping the future of healthcare. The collaboration with Thrive Capital is expected to accelerate the company’s research initiatives and expand its capabilities in delivering groundbreaking treatments to patients in need.
June 15, 2025 - 08:35
Three Women Charged with Grand Larceny in GeneseoGENESEO – Three women from Rochester have been charged with grand larceny following an incident involving the theft of property from a business located in the Genesee Valley Plaza. Authorities...
June 14, 2025 - 23:39
Local Financial Advisor Honored with South Carolina Women in Business AwardA local financial advisor is set to be recognized as a prominent business leader in the community with a South Carolina Women in Business Award. Wendy Brewer, a dedicated professional in the...
June 14, 2025 - 04:22
AI-Generated Ad Shines During NBA FinalsPJ Accetturo, an emerging figure in the realm of AI filmmaking, has revealed the creative process behind the eye-catching Kalshi advertisement that captivated audiences during the NBA Finals....
June 13, 2025 - 05:37
A New Era in Multilingual MeetingsGet ready for a world where meetings can be conducted in multiple languages. The emergence of real-time translation technology is revolutionizing the way businesses communicate across language...